SethDWalkerMD

PubMed

• Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
  Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Sa...> ;The New England journal of medicine. 2019-10-31
• Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-...
  Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard ...> ;Lancet (London, England). 2019-10-31
• 38 citations
  A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis.
  Seth Walker, Patrick A. Flume, John McNamara, Melinda Solomon, Mark A. Chilvers, James Chmiel, R. Scott Harris, Eric L. Haseltine, David Stiles, Chonghua Li, Neil Ahlu...> ;Journal of Cystic Fibrosis. 2019 Sep 1
• 19 citations
  Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial
  Vin Tangpricha, Joshua Lukemire, Yuqing Chen, Jose N. Binongo, Suzanne E. Judd, Ellen S. Michalski, Moon Jeong Lee, Seth Walker, Thomas R. Ziegler, Rabin Tirouvanziam,...> ;The American Journal of Clinical Nutrition. 2019 Mar 1
• VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
  Keating D, Marigowda G, Burr L, Daines C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Sass LA, Tullis E, McKee CM, Moskowitz SM, Robertson S, Savage J, Simard C, Van Goor ...> ;The New England journal of medicine. 2018-10-18
• 164 citations
  Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study
  Margaret Rosenfeld, Claire E. Wainwright, Mark Higgins, Linda T Wang, Charlotte M. McKee, Daniel Campbell, S. Tian, Jennifer Schneider, Steve Cunningham, Jane C. Davie...> ;The Lancet. Respiratory Medicine. 2018 Jul 1
• 202 citations
  Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled, phase 3...
  Felix Ratjen, Christopher Hug, Gautham Marigowda, S. Tian, Xiaohong Huang, Sanja Stanojevic, Carlos E Milla, Paul Robinson, David Waltz, Jane C. Davies, Margaret Rosen...> ;The Lancet. Respiratory Medicine. 2017 Jul 1
• 11 citations
  The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high d...
  Vin Tangpricha, Ellen M. Smith, Jose N. Binongo, Suzanne E. Judd, Thomas R. Ziegler, Seth Walker, Rabindra Tirouvanziam, Susu M. Zughaier, Moon Jeong Lee, Supavit Ches...> ;Contemporary Clinical Trials Communications. 2017 Jun 1
• 17 citations
  Contraceptive safety among women with cystic fibrosis: a systematic review
  Maura K. Whiteman, Titilope Oduyebo, Lauren B. Zapata, Seth Walker, Kathryn M. Curtis> ;Contraception. 2016 Dec 1
• 4 citations
  Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis
  Britta A Staubes, Nicole L. Metzger, Seth Walker, Samuel K. Peasah> ;Pharmacotherapy. 2016 Jun 1
• Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
  Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A,...> ;N Engl J Med. 2015 Jul 16
• 137 citations
  The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
  Colleen S. Kraft, Angela L. Hewlett, Scott A. Koepsell, Anne M. Winkler, Christopher J. Kratochvil, LuAnn Larson, Jay B. Varkey, Aneesh K. Mehta, G. Marshall Lyon, Rac...> ;Clinical Infectious Diseases. 2015 Apr 22
• 6 citations
  Higher mobility scores in patients with cystic fibrosis are associated with better lung function.
  Aneesha Thobani, Jessica A. Alvarez, Shaina Blair, Kaila Jackson, Eric R. Gottlieb, Seth Walker, Vin Tangpricha> ;Pulmonary Medicine. 2015 Feb 18
• Clinical care of two patients with Ebola virus disease in the United States.
  Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Stroher U, Uyeki TM, Ribner BS> ;N Engl J Med. 2014 Dec 18
• 267 citations
  Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.
  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro, Peter Hiatt, Geoffrey Gilmartin, Mark Higgins> ;Journal of Cystic Fibrosis. 2014 Dec 1
• Join now to see all

Journal Articles

• Tidal breathing responses to albuterol and normal saline in infants with viral bronchiolitis  
  (1) Scarlett EE, Walker S, Rovitelli A, and Ren CL, Pediatric Allergy, Immunology, and Pulmonology, 12/1/2012
• Refusal of Venous Thromboembolism Prophylaxis and Incidence of Thrombosis in Patients with Cystic Fibrosis  
  Taryn S. Murray, PharmD, BCPS; Nicole L. Metzger, PharmD, BCPS; Melissa M. Chesson, PharmD, BCPS; Seth D. Walker, MD, PULMONARY RESEARCH AND RESPIRATORY MEDICINE – OPEN JOURNAL, 12/28/2017
• When will the Tobacco Control Act be considered a failure?  
  Walker SD, Austin J Pulm Respir Med, 2014